Symbols / DFTX Stock $22.48 -3.35% Definium Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
DFTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Robert Barrow
Exch · Country NMS · United States
Market Cap 2.24B
Enterprise Value 1.87B
Income -183.79M
Sales —
FCF (ttm) -57.81M
Book/sh 3.36
Cash/sh 4.13
Employees 105
Insider 10d —
IPO Nov 15, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -13.03
PEG —
P/S —
P/B 6.68
P/C —
EV/EBITDA -11.25
EV/Sales —
Quick Ratio 6.17
Current Ratio 6.29
Debt/Eq 12.21
LT Debt/Eq —
EPS (ttm) -2.06
EPS next Y -1.73
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-26
ROA -28.01%
ROE -64.06%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 99.70M
Shs Float 93.69M
Insider Own 1.39%
Instit Own 71.86%
Short Float 9.91%
Short Ratio 5.69
Short Interest 9.82M
52W High 26.25
vs 52W High -14.36%
52W Low 6.03
vs 52W Low 272.80%
Beta 2.56
Impl. Vol. 80.08%
Rel Volume 1.46
Avg Volume 1.76M
Volume 2.57M
Target (mean) $38.53
Tgt Median $37.00
Tgt Low $25.00
Tgt High $70.00
# Analysts 15
Recom Strong_buy
Prev Close $23.26
Price $22.48
Change -3.35%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-10.44
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest DFTX news

No recent news from Yahoo. Try the RSS feed for latest DFTX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-25 SULLIVAN MARK R Officer — 10,702 $18.47 $197,666
2026-03-25 BARROW ROBERT B Chief Executive Officer — 24,431 $18.47 $451,241
2026-03-25 KARLIN DANIEL ROLLINGS Officer — 8,018 $18.47 $148,092
2026-02-03 SULLIVAN MARK R Officer — 125,000 $0.00 $0
2026-02-03 ROBERTS BRANDI L Chief Financial Officer — 150,000 $0.00 $0
2026-02-03 WILEY MATTHEW T Officer — 115,000 $0.00 $0
2026-02-03 BARROW ROBERT B Chief Executive Officer — 320,000 $0.00 $0
2026-02-03 KARLIN DANIEL ROLLINGS Officer — 150,000 $0.00 $0
2025-12-26 SULLIVAN MARK R Officer — 11,276 $13.15 $148,244
2025-12-26 BARROW ROBERT B Chief Executive Officer — 25,791 $13.15 $339,072
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category